Loading...

BDX BECTON DICKINSON & CO Legal Disputes 8-K Filing

BCTN

BDX

BECTON DICKINSON & CO

(BDX)

2026 8-K

FDA Shipment Update

Debt Offering Update

Management Change

Financial Results Announced

Bylaw Amendments

Management Change

Spin-off Update

Tender Offer Update

Tender Offer Announcement

Business Spin-off

Financial Results Announcement

Stock Distribution Announce...

Segment Reorganization

Severance Plan Approved

Stock Fund Blackout

Board Appointments

Financial Results

Management Change

Credit Agreement Update

Financial Statements

Amendments to By-Laws

Financial Statements

Board Appointment

Business Separation

Annual Meeting Results

Management Change

Q4 Financial Results

Hernia Litigation Settlement

Leadership Change

Financial Results Announcement

Notes Offerings

Financial Results Announcement

Departure of Directors

Underwriting Agreements for...

Financial Results Announcement

Annual Meeting Voting Results

Settlement Agreement in Cla...

Departure of Directors or C...

Financial Results Announcement

Amendments to By-laws

Financial Results Announcement

Public Offering

Financial Results Announcement

Entry into Material Definit...

Material Definitive Agreeme...

Underwriting Agreements

Financial Results Announcement

Amendments to Compensation ...

Quantitative Data

Departure of Directors

External Links:

Becton Dickinson & Co has resumed shipments of ChloraPrep™ in the U.S. as of May 29, 2026, following successful final testing after their temporary hold due to an FDA Warning Letter related to its El Paso facility.

AI Assistant

BECTON DICKINSON & CO

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.